Litcius/Paper detail

Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial

Lone B Enebo, Kasper K. Berthelsen, Martin Kankam, Michael Lund, Domenica Rubino, Altynai Satylganova, David C.W. Lau

2021The Lancet302 citationsDOI

Topics & Concepts

TolerabilityMedicineSemaglutidePharmacokineticsPharmacodynamicsConcomitantPharmacologyAdverse effectInternal medicineEndocrinologyLiraglutideDiabetes mellitusType 2 diabetesDiabetes Treatment and ManagementBariatric Surgery and OutcomesMetabolism, Diabetes, and Cancer